ArticleJournal of nanobiotechnology2021

Co-administration of combretastatin A4 nanoparticles and anti-PD-L1 for synergistic therapy of hepatocellular carcinoma.

Bonan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.